Polaprezinc


Indications and Reactions:

Role Indications Reactions
Secondary
Hiv Infection 17.6%
Insomnia 13.1%
Gastritis 8.6%
Headache 8.2%
Anorexia 6.1%
Gastric Ulcer 6.1%
Malnutrition 6.1%
Constipation 4.5%
Hypertension 4.5%
Anaemia 4.1%
Chronic Hepatitis 4.1%
Factor Viii Deficiency 4.1%
Hepatitis C 3.9%
Nausea 2.0%
Oral Candidiasis 2.0%
Vomiting 2.0%
Delirium 0.8%
Glomerulonephritis Rapidly Progressive 0.8%
Ileus 0.8%
Hyperparathyroidism Secondary 0.6%
Pneumonia 35.3%
Pancreatitis Acute 23.5%
Hypoglycaemia 11.8%
Blood Glucose Decreased 5.9%
Diverticulitis 5.9%
Drug Hypersensitivity 5.9%
Eosinophilic Pneumonia 5.9%
Viral Infection 5.9%
Concomitant
Prophylaxis 24.0%
Product Used For Unknown Indication 13.4%
Aplastic Anaemia 12.8%
Infection Prophylaxis 8.9%
Prophylaxis Against Gastrointestinal Ulcer 5.6%
Rheumatoid Arthritis 5.5%
Constipation 4.0%
Insomnia 3.7%
Antiviral Prophylaxis 3.0%
Hypertension 3.0%
Crohn's Disease 2.4%
Anxiety Disorder 2.2%
Drug Use For Unknown Indication 1.8%
Psoriatic Arthropathy 1.6%
Bone Marrow Conditioning Regimen 1.6%
Pain 1.5%
Prophylaxis Against Graft Versus Host Disease 1.4%
Osteoporosis Prophylaxis 1.3%
Premedication 1.3%
Pemphigoid 1.2%
White Blood Cell Count Decreased 13.5%
Staphylococcal Sepsis 7.9%
Pneumonia 7.1%
Anaemia 6.3%
Rash 6.3%
Pyrexia 5.6%
Respiratory Failure 5.6%
Electrocardiogram Qt Prolonged 4.8%
Hyponatraemia 4.8%
Liver Disorder 4.8%
Pancytopenia 4.8%
Pleural Effusion 4.0%
Tongue Neoplasm Malignant Stage Unspecified 4.0%
Epstein-barr Virus Associated Lymphoproliferative Disorder 3.2%
Histiocytosis Haematophagic 3.2%
Lymphoma 3.2%
Stomatitis 3.2%
Tendon Rupture 3.2%
Aortic Dissection 2.4%
Asthma 2.4%

Drug Data